SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001172661-08-000008
Filing Date
2008-01-16
Accepted
2008-01-16 10:16:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G HOLDINGS REPORT avan123107.txt SC 13G 4500
  Complete submission text file 0001172661-08-000008.txt   6413
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-37761 | Film No.: 08532541
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 382 SPRINGFIELD AVENUE, SUITE 500 SUMMIT NJ 07901
Business Address 382 SPRINGFIELD AVENUE, SUITE 500 SUMMIT NJ 07901 908-273-2105
TSP Capital Management Group, LLC (Filed by) CIK: 0001317208 (see all company filings)

IRS No.: 562475911
Type: SC 13G